High-Dose Porcine Galanin Infusion and Effect on Intravenous Glucose Tolerance in Humans

The neuropeptide galanin inhibits glucose-stimulated insulin release in dogs and rodents and has been proposed as having a role in the control of insulin release in humans. The effect of infused galanin on intravenous glucose tolerance in humans was investigated by giving an intravenous glucose tolerance test (0.5 g glucose/kg body wt) alone and with infusions of synthetic porcine galanin at high-dose levels (80 and 160 pmol · kg−1 · min−1) to seven healthy male volunteers. The results showed no effect of galanin infusion on plasma glucose or serum insulin, although a rise in serum growth hormone even in the face of the intravenous glucose load confirmed the potent growth hormone-stimulating effect of galanin. These results suggest that caution should be exercised in extrapolating a physiological role for galanin in humans from the results of animal studies.

[1]  S. Bloom,et al.  Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. , 1989, Gastroenterology.

[2]  K. Hermansen.  Effects of galanin on the release of insulin, glucagon and somatostatin from the isolated, perfused dog pancreas. , 1988, Acta endocrinologica.

[3]  B. Dunning,et al.  Galanin—Sympathetic Neurotransmitter in Endocrine Pancreas? , 1988, Diabetes.

[4]  G. Greenberg,et al.  Effect of Galanin and Vagal Integrity on Insulin Release in Dogs , 1988, Pancreas.

[5]  J. Dupré.  Galanin: a selective inhibitor of insulin secretion? , 1988, Pancreas.

[6]  M. Lazdunski,et al.  ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Bloom,et al.  Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. , 1987, The Journal of clinical endocrinology and metabolism.

[8]  A. Couvineau,et al.  Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization. , 1987, Endocrinology.

[9]  R. Silvestre,et al.  Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro. , 1987, Endocrinology.

[10]  H. Imura,et al.  Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats. , 1987, European journal of pharmacology.

[11]  B. Ahrén,et al.  Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse. , 1987, Acta physiologica Scandinavica.

[12]  G. Greenberg,et al.  The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine. , 1986, Endocrinology.

[13]  J. Burrin,et al.  GROWTH HORMONE RELEASE IN MAN INDUCED BY GALANIN, A NEW HYPOTHALAMIC PEPTIDE , 1986, The Lancet.

[14]  F. Sundler,et al.  Galanin: a novel pancreatic neuropeptide. , 1986, The American journal of physiology.

[15]  J. Polak,et al.  Occurrence and distribution of a newly discovered peptide, galanin, in the mammalian enteric nervous system. , 1986, Gut.

[16]  S. Leibowitz,et al.  Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. , 1986, European journal of pharmacology.

[17]  W. Samson,et al.  Galanin: Evidence for a hypothalamic site of action to release growth hormone , 1986, Peptides.

[18]  P. Anand,et al.  Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury , 1985, Neuroscience.

[19]  N. Ling,et al.  The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. , 1985, The Journal of clinical endocrinology and metabolism.

[20]  Hans Jörnvall,et al.  Galanin — a novel biologically active peptide from porcine intestine , 1983, FEBS letters.

[21]  F. Greenwood,et al.  Studies on the Secretion of Human-pituitary-growth Hormone , 1964, British medical journal.

[22]  E. Lozner,et al.  THE INTRAVENOUS GLUCOSE TOLERANCE TEST. , 1941, The Journal of clinical investigation.